Upgrade to SI Premium - Free Trial

LENZ Therapeutics, Inc. (LENZ)

3.21 +0.06 (1.90%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (Posted Today)

Latest Headlines

LENZ Therapeutics, Inc. (LENZ) Misses Q3 EPS by 8c October 28, 2026 4:58 PM - StreetInsider Form 8-K LENZ Therapeutics, Inc. For: Oct 28 October 28, 2026 4:35 PM - SEC Filing LENZ Therapeutics cuts costs, changes CEO as VIZZ sales rise 50% October 28, 2026 4:33 PM - StreetInsider LENZ Therapeutics Reports Third Quarter 2026 Financial Results, Announces Strategic Consumer Marketing Focused Reorganization and CEO Succession October 28, 2026 4:30 PM - StreetInsider Form SCHEDULE 13G LENZ Therapeutics, Inc. Filed by: BlackRock Portfolio Management LLC October 27, 2026 4:12 PM - SEC Filing LENZ Therapeutics to Report Third Quarter 2026 Financial Results on October 29, 2026 October 22, 2026 8:00 AM - StreetInsider Form SCHEDULE 13G/A LENZ Therapeutics, Inc. Filed by: MILLENNIUM MANAGEMENT LLC October 21, 2026 5:44 PM - SEC Filing LENZ Therapeutics Inc (LENZ) PT Lowered to $50 at TD Cowen October 21, 2026 8:12 AM - StreetInsider LENZ Therapeutics Inc (LENZ) PT Lowered to $5 at Piper Sandler October 19, 2026 7:13 AM - StreetInsider BofA Securities Downgrades LENZ Therapeutics Inc (LENZ) to Neutral August 12, 2026 3:31 PM - StreetInsider LENZ Therapeutics Inc (LENZ) PT Lowered to $7 at Piper Sandler August 12, 2026 9:18 AM - StreetInsider Citi cuts Lenz Therapeutics price target to $10 on slow sales August 12, 2026 6:28 AM - StreetInsider LENZ Therapeutics, Inc. (LENZ) Tops Q2 EPS by 5c August 11, 2026 4:17 PM - StreetInsider Form 10-Q LENZ Therapeutics, Inc. For: Jun 30 August 11, 2026 4:14 PM - SEC Filing Form 8-K LENZ Therapeutics, Inc. For: Aug 11 August 11, 2026 4:09 PM - SEC Filing Full Article List